Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Dec;117(6):1113-1114.
doi: 10.36660/abc.20210935.

A New Therapeutic Alternative for the Treatment of Pulmonary Hypertension?

[Article in English, Portuguese]
Ricardo J Gelpi  1
Affiliations
Editorial

A New Therapeutic Alternative for the Treatment of Pulmonary Hypertension?

[Article in English, Portuguese]
Ricardo J Gelpi. Arq Bras Cardiol. 2021 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Campos C, Turck P, Tavares AMV, Corssac G, Lacerda D, Araujo A, Llesuy S, Klein AB. Effects of Copaiba Oil in Peripheral Markers of Oxidative Stress in a Model of Cor Pulmonale in Rats. Arq Bras Cardiol. 2021;117(6):1106–1112. - PMC - PubMed
    2. Campos C, Turck P, Tavares AMV, Corssac G, Lacerda D, Araujo A, Llesuy S, Klein AB. Effects of Copaiba Oil in Peripheral Markers of Oxidative Stress in a Model of Cor Pulmonale in Rats. Arq Bras Cardiol. 2021; 117(6):1106-1112. - PMC - PubMed
    1. Zimmer A, Teixeira RB, Constantin RL, Fernandes-Piedras TRG, Campos-Carraro C, et al. Thioredoxin system activation is associated with the progression of experimental pulmonary arterial hypertension. Life Sci. 2021 Nov 01;284:119917–119917. - PubMed
    2. Zimmer A, Teixeira RB, Constantin RL, Fernandes-Piedras TRG, Campos-Carraro C, et al. Thioredoxin system activation is associated with the progression of experimental pulmonary arterial hypertension. Life Sci. 2021 Nov 1; 284:119917. - PubMed
    1. Zancan LR, Bruinsmann FA, Paese K, Türck P, Bahr A, Zimmer A, et al. Oral delivery of ambrisentan-loaded lipid-core nanocapsules as a novel approach for the treatment of pulmonary arterial hypertension. Int J Pharm. 2021 Oct 12;610:121181–121181. - PubMed
    2. Zancan LR, Bruinsmann FA, Paese K, Türck P, Bahr A, Zimmer A, et al. Oral delivery of ambrisentan-loaded lipid-core nanocapsules as a novel approach for the treatment of pulmonary arterial hypertension. Int J Pharm. 2021 Oct 12; 610:121181. - PubMed
    1. Zimmer A, Teixeira RB, Constantin RL, Campos-Carraro C, Aparicio Cordero EA, Ortiz VD, et al. The progression of pulmonary arterial hypertension induced by monocrotaline is characterized by lung nitrosative and oxidative stress, and impaired pulmonary artery reactivity. Eur J Pharmacol. 2021 Jan 15;891:173699–173699. - PubMed
    2. Zimmer A, Teixeira RB, Constantin RL, Campos-Carraro C, Aparicio Cordero EA, Ortiz VD, et al. The progression of pulmonary arterial hypertension induced by monocrotaline is characterized by lung nitrosative and oxidative stress, and impaired pulmonary artery reactivity. Eur J Pharmacol. 2021 Jan 15; 891:173699. - PubMed
    1. Campos-Carraro C, Turck P, de Lima-Seolin BG, Tavares AMV, Dos Santos Lacerda D, Corssac GB, et al. Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats. J Cardiovasc Pharmacol. 2018 Nov;72(5):214–221. - PubMed
    2. Campos-Carraro C, Turck P, de Lima-Seolin BG, Tavares AMV, Dos Santos Lacerda D, Corssac GB, et al. Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats. J Cardiovasc Pharmacol. 2018 Nov;72(5):214-21. - PubMed

MeSH terms

Substances